Washington Roundup
January 25, 2002
Contact: Jenny Collier and Tom Leibfried
Legal Action Center
202-544-5478
|
|
Washington Roundup January 25, 2002 |
|
Contact: Jenny Collier and Tom Leibfried Legal Action Center 202-544-5478 |
****SPECIAL EDITION****
Senate Confirms Dr. Andrea Barthwell’s Nomination to Serve as Deputy Director of Demand Reduction at the
Office of National Drug Control Policy: Alcohol and Drug Treatment and Prevention Field Leaders Extremely Pleased
This week, the Senate confirmed Dr. Andrea Barthwell’s nomination to serve as the Deputy Director for Demand Reduction at the White House Office of National Drug Control Policy (ONDCP). Chairman Edward Kennedy (D-MA), Ranking Member Judd Gregg (R-NH), and other members of the of the Senate Health, Education, Labor, and Pensions Committee expressed great support for Dr. Barthwell’s nomination and helped to support her speedy Senate confirmation in the first week of this Congressional session.. Dr. Barthwell was the first Deputy Director to be confirmed at ONDCP, just weeks after John Walters’s confirmation as Drug Czar.
Dr. Barthwell is presently the Executive Vice President of the Human Resources Development Group, the President of the Encounter Medical Group, and the President and CEO of BRASS Foundation, an addiction treatment center in Chicago, Illinois. Additionally, Dr. Barthwell serves as the President of the Board of the American Society of Addiction Medicine and sits on the boards of several alcohol and drug treatment and prevention organizations, including the American Association for the Treatment of Opioid Dependence, the National Council on Alcoholism and Drug Dependence, and the Legal Action Center.
A number of organizations in the drug and alcohol treatment and prevention field actively supported Dr. Barthwell’s nomination during the confirmation process. Field leaders cited her rich experience at both the policy and clinical levels as an indication that she would play an invaluable role as the key advisor to the Bush Administration on drug and alcohol treatment and prevention issues. Advocates and clinicians look forward to Dr. Barthwell’s leadership on these issues.